New sequence variants in patients affected by amyloidosis show transthyretin instability by isoelectric focusing

References

• Vieira M, Saraiva MJ. Transthyretin: a multifaceted protein. Biomol Concepts. 2014;5:45–54.
   PubMedGoogle Scholar
• Blake CC, Geisow MJ, Oatley SJ, et al. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J Mol Biol. 1978;121:339–356.
   PubMed Web of Science ®Google Scholar
• Kanda Y, Goodman DS, Canfield RE, et al. The amino acid sequence of human plasma prealbumin. J Biol Chem. 1974;249:6796–6805.
   PubMed Web of Science ®Google Scholar
• Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2018;25:215–219.
   PubMed Web of Science ®Google Scholar
• Maurer MS, Hanna M, Grogan M, et al. Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). J Am Coll Cardiol. 2016;68:161–172.
   PubMed Web of Science ®Google Scholar
• Buxbaum JN, Tagoe CE. The genetics of the amyloidoses. Annu Rev Med. 2000;51:543–569.
   PubMed Web of Science ®Google Scholar
• Costa PP, Figueira AS, Bravo FR. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA. 1978;75:4499–4503.
   PubMed Web of Science ®Google Scholar
• Connors LH, Lim A, Prokaeva T, et al. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid. 2003;10:160–184.
   PubMed Web of Science ®Google Scholar
• Benson MD. Pathogenesis of transthyretin amyloidosis. Amyloid. 2012;19:14–15.
   PubMed Web of Science ®Google Scholar
• Gertz MA, Benson MD, Dyck PJ, et al. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol. 2015;66:2451–2466.
   PubMed Web of Science ®Google Scholar
• Mitsuhashi S, Yazaki M, Tokuda T, et al. Biochemical characteristics of variant transthyretins causing hereditary leptomeningeal amyloidosis. Amyloid. 2005;12:216–225.
   PubMed Web of Science ®Google Scholar
• Plante-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol. 2011;10:1086–1097.
   PubMed Web of Science ®Google Scholar
• Cornwell GG, Murdoch WL, Kyle RA, et al. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med. 1983;75:618–623.
   PubMed Web of Science ®Google Scholar
• Westermark P, Sletten K, Johansson B, et al. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA. 1990;87:2843–2845.
   PubMed Web of Science ®Google Scholar
• Yazaki M, Higuchi K. Senile systemic amyloidosis. Brain Nerve. 2014;66:817–826.
   PubMedGoogle Scholar
• Saraiva MJ. Transthyretin mutations in health and disease. Hum Mutat. 1995;5:191–196.
   PubMed Web of Science ®Google Scholar
• Saraiva MJ. Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat. 2001;17:493–503.
   PubMed Web of Science ®Google Scholar
• Jiang X, Smith CS, Petrassi HM, et al. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry. 2001;40:11442–11452.
   PubMed Web of Science ®Google Scholar
• Hammarstrom P, Jiang X, Hurshman AR, et al. Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity. Proc Natl Acad Sci U S A. 2002;99:16427–16432.
   PubMed Web of Science ®Google Scholar
• Hammarstrom P, Wiseman RL, Powers ET, et al. Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science. 2003;299:713–716.
   PubMed Web of Science ®Google Scholar
• Altland K, Benson MD, Costello CE, et al. Genetic microheterogeneity of human transthyretin detected by IEF. Electrophoresis. 2007;28:2053–2064.
   PubMed Web of Science ®Google Scholar
• McCutchen SL, Colon W, Kelly JW. Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry. 1993;32:12119–12127.
   PubMed Web of Science ®Google Scholar
• Altland K, Winter P, Sauerborn MK. Electrically neutral microheterogeneity of human plasma transthyretin (prealbumin) detected by isoelectric focusing in urea gradients. Electrophoresis. 1999;20:1349–1364.
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Mizuguchi M, Kouno T, et al. Destabilization of transthyretin by pathogenic mutations in the DE loop. Proteins. 2007;66:716–725.
   PubMed Web of Science ®Google Scholar
• Leach BI, Zhang X, Kelly JW, et al. NMR measurements reveal the structural basis of transthyretin destabilization by pathogenic mutations. Biochemistry. 2018;57:4421–4430.
   PubMed Web of Science ®Google Scholar
• Pont L, Sanz-Nebot V, Vilaseca M, et al. A chemometric approach for characterization of serum transthyretin in familial amyloidotic polyneuropathy type I (FAP-I) by electrospray ionization-ion mobility mass spectrometry. Talanta. 2018;181:87–94.
   PubMed Web of Science ®Google Scholar
• Martinez-Ulloa PL, Vallejo M, Corral I, et al. A novel ATTR L32V mutation causes familial amyloid polyneuropathy in a Bolivian family. J Peripher Nerv Syst. 2017;22:208–212.
   PubMed Web of Science ®Google Scholar
• Altland K, Banzhoff A. Separation by hybrid isoelectric focusing of normal human plasma transthyretin (prealbumin) and a variant with a methionine for valine substitution associated with familial amyloidotic polyneuropathy. Electrophoresis. 1986;7:529–533.
   Web of Science ®Google Scholar
• Altland K, Banzhoff A, Becher P. Paraffin oil protected high resolution hybrid isoelectric focusing for the demonstration of substitutions of neutral amino acids in denatured proteins: The case of four human transthyretin (prealbumin) variants associated with familial myloidotic polyneuropathy. Electrophoresis. 1987;8:293–297.
   Web of Science ®Google Scholar
• Connors LH, Ericsson T, Skare J, et al. A simple screening test for variant transthyretins associated with familial transthyretin amyloidosis using isoelectric focusing. Biochim Biophys Acta. 1998;1407:185–192.
   PubMed Web of Science ®Google Scholar
• Jenne DE, Denzel K, Blatzinger P, et al. A new isoleucine substitution of Val-20 in transthyretin tetramers selectively impairs dimer-dimer contacts and causes systemic amyloidosis. Proc Natl Acad Sci USA. 1996;93:6302–6307.
   PubMed Web of Science ®Google Scholar
• Bauer R, Dikow N, Brauer A, et al. The "Wagshurst study": p.Val40Ile transthyretin gene variant causes late-onset cardiomyopathy. Amyloid. 2014;21:267–275.
   PubMed Web of Science ®Google Scholar
• Dohrn MF, Rocken C, De Bleecker JL, et al. Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy. J Neurol. 2013;260:3093–3108.
   PubMed Web of Science ®Google Scholar
• Rowczenio DM, Noor I, Gillmore JD, et al. Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum Mutat. 2014;35:E2403–E2412.
   PubMed Web of Science ®Google Scholar
• Altland K, Richardson SJ. Histidine 31: The Achilles' heel of human transthyretin. microheterogeneity is not enough to understand the molecular causes of amyloidogenicity. In: Richardson SJ, Cody V, editors. Recent Advances in Transthyretin Evolution, Structure and Biological Functions. Berlin Heidelberg (Germany): Springer; 2009. p. 201–214.
   Google Scholar
• Alves IL, Altland K, Almeida MR, et al. Screening and biochemical characterization of transthyretin variants in the Portuguese population. Hum Mutat. 1997;9:226–233.
   PubMed Web of Science ®Google Scholar
• Azevedo EP, Pereira HM, Garratt RC, et al. Dissecting the structure, thermodynamic stability, and aggregation properties of the A25T transthyretin (A25T-TTR) variant involved in leptomeningeal amyloidosis: identifying protein partners that co-aggregate during A25T-TTR fibrillogenesis in cerebrospinal fluid. Biochemistry. 2011;50:11070–11083.
   PubMed Web of Science ®Google Scholar